Jennifer Koblinski

12PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Sacituzumab Govitecan as an Effective Strategy for Sensitizing Chemoresistant HNSCC Cells to Senolytic Intervention.

|Feb 06, 2026
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis.

Neil G Patel, Alexandra Drakaki, Farhan Valummel

|Sep 23, 2024
The Innate Immune System and the TRAIL-Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females.

Lauren May, Bin Hu, Preksha Jerajani

|Sep 20, 2024
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis.

Kranthi Kumar Chougoni, Victoria Neely, Boxiao Ding

|May 07, 2024
The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.

Shanwei Shen, Senthil K Radhakrishnan, J Chuck Harrell

|Nov 24, 2021
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer.

James D Hampton, Erica J Peterson, Samantha J Katner

Pageof 2

Frequent Collaborators

3 joint publications

Mikhail G Dozmorov

2 joint publications

Hisashi Harada

2 joint publications

Senthil K Radhakrishnan

2 joint publications

Bin Hu